You have 9 free searches left this month | for more free features.

maintenance therapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Breast Cancer Trial (XC, TPC)

Not yet recruiting
  • Advanced Breast Cancer
  • (no location specified)
May 16, 2023

Nasopharyngeal Carcinoma, Maintenance Therapy Trial in Guangzhou (Capecitabine/Placebo combined with treprizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Maintenance Therapy
  • Capecitabine/Placebo combined with treprizumab
  • Guangzhou, Guangdong, China
    SunYat-senU
May 11, 2023

Depression Trial (intermittend theta burst stimulation)

Not yet recruiting
  • Depression
  • intermittend theta burst stimulation
  • (no location specified)
Feb 20, 2023

Penpulimab in Maintenance Therapy in Lymphoma

Not yet recruiting
  • Lymphoma
  • (no location specified)
Dec 25, 2022

Colorectal Cancer Trial (Regorafenib)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 17, 2023

Pemphigus, Dermatologic Disease Trial (RiTUXimab Injection)

Not yet recruiting
  • Pemphigus
  • Dermatologic Disease
  • RiTUXimab Injection
  • (no location specified)
Jun 7, 2023

Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Aurora (Mirvetuximab Soravtansine, Olaparib)

Not yet recruiting
  • Ovary Cancer
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
May 30, 2023

Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

Not yet recruiting
  • Myeloid Malignancy
  • Acute Myeloid Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023

Castration Sensitive Prostate Cancer Trial in Little Rock (Metformin, Turmeric)

Not yet recruiting
  • Castration Sensitive Prostate Cancer
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 12, 2023

Endometrial Cancer Trial (Navtemadlin, Navtemadlin Placebo)

Not yet recruiting
  • Endometrial Cancer
  • (no location specified)
Mar 21, 2023

Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 25, 2023

MDD Trial in Providence (EMA Monitoring, Scheduling Maintenance TMS sessions)

Recruiting
  • Major Depressive Disorder
  • EMA Monitoring
  • Scheduling Maintenance TMS sessions
  • Providence, Rhode Island
    Butler Hospital
Nov 28, 2023

Ovarian Cancer Trial in Houston (Shared Medical Decision Tool, Engaging Patients in Decision Making, Literacy Spanish Language)

Recruiting
  • Ovarian Cancer
  • Shared Medical Decision Tool
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2023

Multiple Myeloma Trial in Houston (Isatuximab, lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2023

Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • quaratusugene ozeplasmid
  • atezolizumab
  • (no location specified)
Jan 19, 2023

First-line Olaparib Combined With Bevacizumab Maintenance

Not yet recruiting
  • Ovarian Neoplasms
  • olaparib plus bevacizumab maintenance therapy
  • (no location specified)
Jun 29, 2022

T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

Recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 7, 2023

Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jun 6, 2023

Ovarian Tumors Trial in Nanjing (Niraparib)

Completed
  • Ovarian Neoplasms
  • Nanjing, China
    Zhongda hospital
Feb 17, 2023

Gastric Cancer Trial (Fruquintinib+PD-1)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Feb 1, 2023

Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +2 more
  • Wuhan, Hubei, China
    Institute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023

Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia
  • Venclexta 100 MG Oral Tablet
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023

Colorectal Cancer, Liver Metastases, Circulating Tumor Cell Trial in GuangZhou (Colorectal resection surgery., FOLFOX chemo

Recruiting
  • Colorectal Cancer
  • +3 more
  • Colorectal resection surgery.
  • +2 more
  • GuangZhou, Guangdong, China
    The Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 3, 2023

Metastatic Breast Cancer Trial in Taipei City, Taipei, Yuanlin (Olaparib, Chemotherapy drug)

Recruiting
  • Metastatic Breast Cancer
  • Taipei City, Please Select, Taiwan
  • +2 more
Nov 27, 2022

Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor Trial in Petaling Jaya (Dendritic cell + Cytokine-induced killer cell

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Advanced Solid Tumor
  • Dendritic cell + Cytokine-induced killer cell (DC+CIK) immunotherapy
  • Tegafur Only Product
  • Petaling Jaya, Kuala Lumpur, Malaysia
    Clinical Oncology Department, Ummc
Jul 12, 2023